Notes 20100325.123045 Special Exosomes Tiny Bubbles
From SnOwy - Ed's Wiki Notebook
Contents |
Abbreviations
- MHC: Major Histocompatibility Complex
- APC: Antigen Presenting Cells
Notes
- immunological significance
- exosome background
- immunology background
- dendritic cell derived exosomes
Exosome Backgrounds
- nanovesicles from endosomes
- 30-100nm diameter circles
- supernatant at 100kG ultracentrifugation
- suite of proteins
- exosomes contain particular proteins
- adhesion molecules on membrane
- MHC molecules on membrane
Endosomal Origin
- exosomes are produced in multivesicular bodies which fuse to plasmalemma to release exosomes
- exosomes MHC may bind with plasmalemma
- exosomes are formed by plasmalemma invagination
Discovery
- transferrin receptor degredation
- RBCs do not have them, instead of lysosomal degredation, these transferrin receptors are launched on exosomes
- 1996 exosomes with MHC II molecules secreted by B cells, stimulated research...
- immune function of exosomes
- especially dendritic cells
- secreted by many (all?) cell types
- can spread prions between cells
- virus spreading (Trojan exosome hypothesis)
Today
- exosomes contain mRNA and microRNA
- transcripts can shuttle between cells!
- shown that the transcripts are actually translated in recipient cells
MHC I Background
- a protein that loads and presents proteins on a cell surface
MHC II Background
- may only be used by antigen-presenting cells
- a T cell will dock with a corresponding MHC and an antigen
- dendritic cells as APCs
- dendritic cells present three signals to T cells -- look up later
- cancer immunotherapy
- tumour cells express antigens that aren't self
Dendritic cell derived exosomes (DEX)
- method: pulsing a dendritic cell with transcripts from a tumour
- result: dendritic cells able to present tumour translations
- allowed killer T cells to now recognize tumour cells
- Thery et al., 2002
- with this method, mouse immune system able to clear away 40% to 60% of transformed tumour cells
- when injected with irrelevant tumour: no protection (negative control OK)
- if athymic: no protection (negative control OK)
- exosomes used to deliver such antigens to the dendritic cells
- Morelli et al., 2004
- Phase I clinical trials underway, Curie, Duke
- Able to get enough DEX in terms of MHC II molecules
- Curie: no T cell response?
- Duke: increased survival time, T cell (1 patient), NK cell activation (1 patient)
- Andre et al., 2004
- immature DEX (iDEX) needed by mature dendritic cells (mDC) to be present
- same in vivo
- many other studies mentioned which varied the treatment and the corresponding antigens etc.,
Dendritic Cell + DEX
- naked peptides degrade too quickly
- DEX are more stable than dendritic cells and can be artificially manufactured
- activates NK cells
- possible activation of more cell mediated immune responses?
- other cells that release exosomes that have immune function
- intestinal epithelial cells (uses MHC II)
- what about the basement membrane?
- secretion of exosomes, T cells can read the exosomes-- easily fits through basement membrane
- macrophages release exosomes carrying PAMPs when they contact pathogens
- mast cells activate B cells and T cells with exosomes?
Future
- DEX vaccines to suppress immune responses
- appears to work in mice to address autoimmune disorders